Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

INTRODUCTION: Mutations in PTPN11 are associated with Noonan syndrome (NS). Although the effectiveness of growth hormone therapy (GHT) in treating short stature due to NS has been previously demonstrated, the effect of PTPN11 mutation status on the long-term outcomes of GHT remains to be elucidated....

Descripción completa

Detalles Bibliográficos
Autores principales: Jorge, Alexander A L, Edouard, Thomas, Maghnie, Mohamad, Pietropoli, Alberto, Kelepouris, Nicky, Romano, Alicia, Zenker, Martin, Horikawa, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066595/
https://www.ncbi.nlm.nih.gov/pubmed/35245205
http://dx.doi.org/10.1530/EC-21-0615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066595/
https://www.ncbi.nlm.nih.gov/pubmed/35245205
http://dx.doi.org/10.1530/EC-21-0615

Ejemplares similares